These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 35120040)
1. Therapeutic Hyperthermia Is Associated With Improved Survival in Afebrile Critically Ill Patients With Sepsis: A Pilot Randomized Trial. Drewry AM; Mohr NM; Ablordeppey EA; Dalton CM; Doctor RJ; Fuller BM; Kollef MH; Hotchkiss RS Crit Care Med; 2022 Jun; 50(6):924-934. PubMed ID: 35120040 [TBL] [Abstract][Full Text] [Related]
2. Multi-centre, three arm, randomized controlled trial on the use of methylprednisolone and unfractionated heparin in critically ill ventilated patients with pneumonia from SARS-CoV-2 infection: A structured summary of a study protocol for a randomised controlled trial. Busani S; Tosi M; Mighali P; Vandelli P; D'Amico R; Marietta M; Forfori F; Donati A; Cinnella G; De Monte A; Pasero D; Bellani G; Tascini C; Foti G; Ranieri M; Girardis M Trials; 2020 Aug; 21(1):724. PubMed ID: 32807241 [TBL] [Abstract][Full Text] [Related]
3. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
4. Monocyte Function and Clinical Outcomes in Febrile and Afebrile Patients With Severe Sepsis. Drewry AM; Ablordeppey EA; Murray ET; Dalton CM; Fuller BM; Kollef MH; Hotchkiss RS Shock; 2018 Oct; 50(4):381-387. PubMed ID: 29240644 [TBL] [Abstract][Full Text] [Related]
6. Early versus late tracheostomy in critically ill COVID-19 patients. Szafran A; Dahms K; Ansems K; Skoetz N; Monsef I; Breuer T; Benstoem C Cochrane Database Syst Rev; 2023 Nov; 11(11):CD015532. PubMed ID: 37982427 [TBL] [Abstract][Full Text] [Related]
7. Antiviral and immunomodulatory interferon-beta in high-risk COVID-19 patients: a structured summary of a study protocol for a randomised controlled trial. Aricò E; Castiello L; Bracci L; Urbani F; Lombardo F; Bacigalupo I; Ancidoni A; Vanacore N; Falcione A; Reggiani C; Dutti GM; Maglie MG; Papa O; Bartoletti PL; Ozzella G; Bevilacqua N; Nicastri E; Belardelli F; Sconocchia G Trials; 2021 Sep; 22(1):584. PubMed ID: 34479601 [TBL] [Abstract][Full Text] [Related]
8. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial. Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739 [TBL] [Abstract][Full Text] [Related]
9. Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a structured summary of a study protocol. Marietta M; Vandelli P; Mighali P; Vicini R; Coluccio V; D'Amico R; Trials; 2020 Jun; 21(1):574. PubMed ID: 32586394 [TBL] [Abstract][Full Text] [Related]
10. A pilot study of therapeutic plasma exchange for serious SARS CoV-2 disease (COVID-19): A structured summary of a randomized controlled trial study protocol. Faqihi F; Alharthy A; Alodat M; Asad D; Aletreby W; Kutsogiannis DJ; Brindley PG; Karakitsos D Trials; 2020 Jun; 21(1):506. PubMed ID: 32513290 [TBL] [Abstract][Full Text] [Related]
11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
12. Comparison of monocyte human leukocyte antigen-DR expression and stimulated tumor necrosis factor alpha production as outcome predictors in severe sepsis: a prospective observational study. Drewry AM; Ablordeppey EA; Murray ET; Beiter ER; Walton AH; Hall MW; Hotchkiss RS Crit Care; 2016 Oct; 20(1):334. PubMed ID: 27760554 [TBL] [Abstract][Full Text] [Related]
13. Nebulised surfactant for the treatment of severe COVID-19 in adults (COV-Surf): A structured summary of a study protocol for a randomized controlled trial. Dushianthan A; Clark H; Madsen J; Mogg R; Matthews L; Berry L; de la Serna JB; Batchelor J; Brealey D; Hussell T; Porter J; Djukanovic R; Feelisch M; Postle A; Grocott MPW Trials; 2020 Dec; 21(1):1014. PubMed ID: 33302976 [TBL] [Abstract][Full Text] [Related]
14. Hydroxyethyl starch for fluid resuscitation in critically ill patients. Bagshaw SM; Chawla LS Can J Anaesth; 2013 Jul; 60(7):709-13. PubMed ID: 23604905 [TBL] [Abstract][Full Text] [Related]
15. Letter to the editor: efficacy of different methods of combination regimen administrations including dexamethasone, intravenous immunoglobulin, and interferon-beta to treat critically ill COVID-19 patients: a structured summary of a study protocol for a randomized controlled trial. Abdolahi N; Kaheh E; Golsha R; Khodabakhshi B; Norouzi A; Khandashpoor M; Besharat S; Tavassoli S; Livani S; Azimi SA; Gharib MH; Peivandi B; Fazel A; Shirzad-Aski H; Roshandel G Trials; 2020 Jun; 21(1):549. PubMed ID: 32560745 [TBL] [Abstract][Full Text] [Related]
16. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study. Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796 [TBL] [Abstract][Full Text] [Related]
17. Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19). Urwyler P; Charitos P; Moser S; Heijnen IAFM; Trendelenburg M; Thoma R; Sumer J; Camacho-Ortiz A; Bacci MR; Huber LC; Stüssi-Helbling M; Albrich WC; Sendi P; Osthoff M Trials; 2021 Jan; 22(1):1. PubMed ID: 33397449 [TBL] [Abstract][Full Text] [Related]
18. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial. Sholzberg M; Tang GH; Negri E; Rahhal H; Kreuziger LB; Pompilio CE; James P; Fralick M; AlHamzah M; Alomran F; Tseng E; Lim G; Lillicrap D; Carrier M; Áinle FN; Beckett A; da Costa BR; Thorpe K; Middeldorp S; Lee A; Cushman M; Jüni P Trials; 2021 Mar; 22(1):202. PubMed ID: 33691765 [TBL] [Abstract][Full Text] [Related]
19. Therapeutic Hyperthermia Is Associated With Improved Survival in Afebrile Critically Ill Patients With Sepsis: A Pilot Randomized Trial. Kula R Crit Care Med; 2022 Aug; 50(8):e693-e694. PubMed ID: 35838268 [No Abstract] [Full Text] [Related]
20. A phase II, single-center, double-blind, randomized placebo-controlled trial to explore the efficacy and safety of intravenous melatonin in patients with COVID-19 admitted to the intensive care unit (MelCOVID study): a structured summary of a study protocol for a randomized controlled trial. Rodríguez-Rubio M; Figueira JC; Acuña-Castroviejo D; Borobia AM; Escames G; de la Oliva P Trials; 2020 Aug; 21(1):699. PubMed ID: 32758298 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]